Signia Announces New HandsFree Phone Call Feature for its Augmented Xperience Hearing Aids

Augmented Xperience: Furthering its mission to enhance human performance, hearing aid innovator Signia today announced that its breakthrough Augmented Xperience (AX) hearing aid platform will now support hands-free phone calls. The HandsFree feature upgrade will be available Spring 2022 for all new and existing AX hearing aids paired with iOS devices.

By utilizing the HandsFree feature, consumers with select iOS devices will be able to hold conversations through their Signia AX hearing aids without having to speak directly into their phone or tablet. Instead, the hearing aids’ microphones will pick up the wearer’s voice and transmit it to the conversation partner at the other end of the line via Bluetooth®.

“With the HandsFree upgrade, wearers can keep their phone comfortably stowed in their pocket, purse, or even across the room whenever they take a call,” stated Mike O’Neil, President of Signia USA. “The HandsFree feature further underscores our commitment to enhancing human performance through optimized hearing – even when the conversation isn’t taking place in-person.”

This new upgrade marks the latest in Signia’s ongoing commitment to providing consumers with the effortless streaming and connectivity they require to enhance their performance – whether that be in in-person or on the phone.

Leveraging the benefits of Signia AX technology for hands-free phone calls

Through the Augmented Xperience platform, wearers benefit from outstanding speech clarity when taking hands-free calls at home, in the office, or on a busy street. Rather than simply amplifying all sounds, the AX platform intelligently understands which sounds should be pulled to the foreground and prioritized, and which sounds should remain in the background.

Rooted in the first-of-its-kind Augmented Focus™ technology – which leverages two independent processors to address speech and background noise separately – speech becomes closer to the wearer while surrounding sounds stay in the background.

Studies have shown that Signia AX results in greater than 25 percent better speech understanding in noise compared to users’ own hearing aids. Additionally, 95% of study participants reported excellent speech understanding in their home environment.[1]

Signia AX has proven to change how wearers hear the world in quiet, moderate and noisy environments. By elevating the listening experience in all surroundings, wearers can enjoy a fully immersive soundscape anywhere they take a hands-free phone call.

“The HandsFree feature is one of several additional innovative features in the pipeline for the AX platform,” added O’Neil. “When hearing care professionals fit a patient with Signia AX hearing aids, they can be confident that they’re giving patients not only an exceptional solution today, but also one that’s future-proofed for tomorrow.”

The HandsFree feature will be available in all new and existing Signia AX hearing aids through an update in Spring 2022.

SourceSignia
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version